# Strategic Decision & Roadmap for Research Cycle 5
**Program:** AEGIS-01 / Research Cycle 4B  
**Author:** AEGIS Survivability Systems Engineering  
**Date:** 2026-11-09  
**Status:** Approved Strategic Decision Directive (`DEC-0028`)  

---

## 1. Context & Retrospective

Research Cycle 4B marked the definitive transition of AEGIS-01 from theoretical model accumulation to **rigorous external quantitative validation**.

Through the execution of the Three-Track External Validation Gate (`EXP-0069`):
1. Native biomaterials mechanics (`MODEL-12`) were validated against peer-reviewed test coupons with $0.50\%$ mean error.
2. Clinical functional muscle recovery (`MODEL-13`) was verified against the 13-patient IPD cohort of Dziki et al. (2016) with a validation set $\text{MAE} = 5.92\%$.
3. Coupled thermoregulatory strain under CPE45 (`MODEL-14`) was calibrated against ISO 7933:2023 with a warming rate discrepancy of just $0.005\text{ K/min}$.
4. Critical numerical and epistemic errors were permanently excised (`INV-0015`, `INV-0016`, `NEG-0064`, `NEG-0065`).

With 14 models verified, 108 automated unit tests passing, zero cross-repo collisions, and physical conservation laws verified to $<10^{-12}\text{ W}$, the project faces a pivotal strategic choice for Cycle 5.

---

## 2. Evaluation of Strategic Alternatives for Cycle 5

### Option A: Broad Exploratory Model Expansion
- **Concept:** Introduce additional computational models (e.g., MODEL-15 through MODEL-20) covering extreme speculative topics such as full-body endoskeletal carbon lattices, radiation shielding biology, or aquatic fluid dynamics.
- **Evaluation:** **REJECTED**. Adding further uncalibrated models expands the epistemic debt of the program without increasing operational utility or scientific defensibility. Success is defined by empirical fidelity, not model count.

### Option B: Pure Biological Morphogenetic Engineering (ARCH-BIO Focus)
- **Concept:** Focus exclusively on the developmental biology and gene regulatory networks required to induce endogenous pangolin scale morphogenesis in human epidermal keratinocytes.
- **Evaluation:** **DEFERRED**. External validation in Cycle 4B demonstrated that ARCH-BIO suffers from a fatal physiological failure mode: occluding $40\%$ of human skin precipitates uncompensable hyperthermia ($39.5^\circ\text{C}$) in $27.6\text{ minutes}$ in tropical climates. Investing heavily in morphogenetic expression before solving the thermal dissipation barrier is inefficient.

### Option C: Focused Biohybrid Engineering & Live Empirical Protocol Design (ARCH-HYBRID Focus)
- **Concept:** Focus all analytical and computational resources on **ARCH-HYBRID** as the primary viable pathway for operational survivability. Formulate actionable physical testing protocols (drop-tower impact, fragment penetration, microvascular perfusion finite-element modeling) and finalize deep integration with SUBJECT-01's motor-unit biomechanics.
- **Evaluation:** **ADOPTED**. ARCH-HYBRID preserves $92\%$ of eccrine thermoregulatory skin, achieves the highest Pareto trade-off score (0.842), and builds directly upon clinically established technologies (porous titanium osseointegration, ECM scaffolding).

---

## 3. Cycle 5 Strategic Objectives & Scope

### Objective 1: Drop-Tower & Dynamic Impact Protocol Formulation
Develop standardized ASTM/NIJ-compliant testing protocols for biohybrid armor coupons (titanium trabecular matrix infiltrated with cross-linked keratin and collagenous damping layers), specifying:
- Strain-rate dependent dynamic fracture mechanics ($d\epsilon/dt > 10^3\text{ s}^{-1}$).
- Blunt Behind-Armor Trauma (BABT) transmission through living tissue analogs (pericardial/thoracic surrogates).

### Objective 2: Localized Micro-Perforation Bio-Heat FEA
Extend `MODEL-14` from lumped-parameter compartments to a 3D finite-element formulation of cutaneous thermoregulation:
- Model the heat transfer impact of localized armor fenestrations and active dermal cooling channels.
- Evaluate transient core temperature recovery during intermittent rest cycles in tropical environments.

### Objective 3: Motor-Unit Functional Re-innervation Coupling with SUBJECT-01
Bridge `MODEL-13` functional regeneration with SUBJECT-01 neuromuscular recruitment models:
- Simulate individual motor unit territory remodeling following mixed-nerve trauma treated with PEG-fusion and ECM scaffolds.
- Quantify rate of force development (RFD) and synkinetic co-contraction penalties during complex motor actions.

### Objective 4: Canonical Integration PR to SUBJECT-01 Main
Upon completion of Cycle 5 verification, submit the formal Pull Request merging the `research/aegis_survivability` package into the canonical `main` branch of SUBJECT-01 without modifying active development worktrees.

---

## 4. Formal Decision Record (`DEC-0028`)

- **Decision:** Formal adoption of Option C (Focused Biohybrid Engineering & Physical Protocol Design) as the official directive for AEGIS-01 Research Cycle 5.
- **Primary Architecture Focus:** `ARCH-HYBRID`.
- **Epistemic Standard:** All new parameters must be classified under the Six-Tier Scientific Status Classification established in `DEC-0027`.
